A detailed history of Morgan Stanley transactions in Kempharm, Inc stock. As of the latest transaction made, Morgan Stanley holds 127,483 shares of KMPH stock, worth $629,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127,483
Previous 62,639 103.52%
Holding current value
$629,766
Previous $309,000 103.56%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
64,844 Added 103.52%
127,483 $629,000
Q2 2024

Oct 17, 2024

SELL
N/A
-27,488 Reduced 30.5%
62,639 $309,000
Q2 2024

Aug 14, 2024

SELL
N/A
-27,488 Reduced 30.5%
62,639 $309,000
Q1 2024

Oct 17, 2024

BUY
N/A
27,488 Added 43.88%
90,127 $445,000
Q1 2024

Aug 16, 2024

BUY
N/A
15,984 Added 21.56%
90,127 $445,000
Q1 2024

May 15, 2024

BUY
N/A
15,984 Added 21.56%
90,127 $445,000
Q4 2023

Aug 16, 2024

BUY
N/A
11,504 Added 18.37%
74,143 $366,000
Q4 2023

Feb 13, 2024

BUY
N/A
46,232 Added 165.64%
74,143 $366,000
Q3 2023

Nov 15, 2023

SELL
N/A
-23,539 Reduced 45.75%
27,911 $137,000
Q2 2023

Aug 14, 2023

BUY
$4.94 - $6.29 $16,124 - $20,530
3,264 Added 6.77%
51,450 $254,000
Q1 2023

May 15, 2023

BUY
$4.13 - $6.27 $155,767 - $236,479
37,716 Added 360.23%
48,186 $265,000
Q4 2022

Feb 14, 2023

SELL
$4.12 - $5.62 $29,416 - $40,126
-7,140 Reduced 40.55%
10,470 $48,000
Q3 2022

Nov 14, 2022

SELL
$4.5 - $6.85 $170,838 - $260,053
-37,964 Reduced 68.31%
17,610 $109,000
Q2 2022

Oct 27, 2022

BUY
$4.02 - $5.21 $165,632 - $214,662
41,202 Added 286.68%
55,574 $248,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $5.21 $165,632 - $214,662
41,202 Added 286.68%
55,574 $248,000
Q1 2022

Oct 27, 2022

SELL
$5.0 - $9.26 $206,010 - $381,530
-41,202 Reduced 74.14%
14,372 $72,000
Q1 2022

May 13, 2022

SELL
$5.0 - $9.26 $10,240 - $18,964
-2,048 Reduced 12.47%
14,372 $72,000
Q4 2021

Feb 14, 2022

SELL
$7.6 - $10.26 $206,948 - $279,379
-27,230 Reduced 62.38%
16,420 $143,000
Q3 2021

Nov 15, 2021

BUY
$8.72 - $13.31 $380,628 - $580,981
43,650 New
43,650 $407,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.